To ask the Secretary of State for Health and Social Care, what assessment has he made of the potential merits of expanding the use of medical cannabis.

No assessment has been made. Licensed cannabis-based medicines are routinely available on the National Health Service, however, clinical guidelines from the National Institute for Health and Care Excellence demonstrate a clear need for more evidence to support routine prescribing and funding decisions for unlicensed cannabis based products for medicinal use in humans. Until that evidence base is built, prescribers will remain reticent to prescribe and no decision can be made by the NHS on routine funding.

We continue to call on manufacturers to conduct research and we are working with regulatory, research and NHS partners to establish clinical trials to test the safety and efficacy of these products.